Diseases, Conditions, Syndromes

FDA approves Rinvoq for treatment of atopic dermatitis

The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

Alzheimer's disease & dementia

Pharmacists in care teams improve care for patients with dementia

Problems related to elderly patients' medical drug treatments are widespread and commonly result in hospital admissions for people with dementia. New research shows that including clinical pharmacists in health care teams ...

Medical research

UK must not fall behind in race to 'humanize' drug discovery

Researchers writing in the Journal of the Royal Society of Medicine are warning that current research models and regulation are blocking the development of human-relevant approaches to drug discovery and are perpetuating ...

Neuroscience

New genetic test can predict adverse reactions to epilepsy drug

A study led by researchers at RCSI (Royal College of Surgeons in Ireland) has identified a new genetic test that can be used to predict if a patient with epilepsy will develop an adverse reaction to a common anti-epileptic ...

page 3 from 28